Table 2 Characteristics of the included studies
Surname(Year) | Country | Cancer type | Total number | High | Low | Cut-off(high/low) | Detection method | Quality score |
|---|---|---|---|---|---|---|---|---|
T Lei(2018 April) [25] | China | non-small cell lung cancer | 69 | 34 | 35 | mean | qRT‒PCR | 6 |
TL Zheng(2018 September) [26] | China | non-small cell lung cancer | 60 | 30 | 30 | median | qRT‒PCR | 8 |
DL Wang(2020 July) [39] | China | non-small cell lung cancer | 162 | 80 | 82 | mean | qRT‒PCR | 6 |
J Liu(2017 May) [24] | China | glioblastoma | 48 | 24 | 24 | median | qRT‒PCR | 7 |
C Yang(2017 October) [27] | China | osteosarcoma | 60 | 30 | 30 | median | qRT‒PCR | 8 |
JJ Yan(2018 November) [28] | China | gastric cancer | 78 | 34 | 44 | fold-change = 2 | qRT‒PCR | 7 |
S Xue(2015 April) [40] | China | clear cell renal cell carcinoma | 98 | 49 | 49 | median | qRT‒PCR | 6 |
PN Hu(2015 August) [30] | China | breast cancer | 716 | 555 | 161 | NA | qRT‒PCR | 7 |
CS Yan(2017 April) [31] | China | ovarian cancer | 57 | 28 | 29 | median | qRT‒PCR | 7 |
L Wei(2021 January) [32] | China | hepatocellular carcinoma | 80 | 40 | 40 | median | qRT‒PCR | 7 |
Gaurav Kumar Pandey(2014 November) [20] | Sweden | neuroblastoma | 93 | 50 | 43 | NA | qRT‒PCR | 9 |
Dan Du(2017 June) [33] | China | bladder cancer | 79 | 45 | 34 | median ratio of relative NBAT1 expression = 0.5 | qRT‒PCR | 6 |